Delivery Order SPE2DB22D3301-SPE2DB26FX4DY
Award Date 10/31/25
Potential Completion Date 11/24/25
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $24,673.08 to AmerisourceBergen Drug Corp for the supply of HEMLIBRA 105 mg/0.7 ml vials. This is a firm fixed-price, non-set-aside contract with a completion date of August 8, 2025, and was awarded on July 18, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order operates under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,564.08 firm fixed-price delivery order is for the supply of HEMLIBRA 150 MG/ML VIALML, a critical medical product, with a period of performance through January 22, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Hemlibra 105 mg/0.7 mL vials with a ceiling value of $24,673.08 under a firm fixed-price contract structure. This delivery order, which is scheduled for completion by November 17, 2025, represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The award is executed as a child contract under...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical worth $32,885.08 to supply HEMLIBRA 150 MG/ML VIALML pharmaceutical products. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with completion by November 2023. This order was awarded against an indefinite delivery contract held by Amerisourcebergen with no set-aside designation specified. As a leading pharmaceutical...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,336.54 firm fixed-price delivery order contract is for the supply of HEMLIBRA 105 MG/0.7 ML VIAL 0.7ML, a specialty medication. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $6,168.26 and has a completion date of February 24, 2025. It is for the delivery of HEMLIBRA 105 MG/0.7 ML VIAL 0.7ML, a specialty pharmaceutical product. The contract is a firm fixed-price delivery order, with no set-aside designation indicated. AmerisourceBergen holds a larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,409.40 firm fixed-price delivery order is for Hemlibra 150 mg/mL vial, a specialty medication. It has an ultimate completion date of August 2, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,641.02 Firm Fixed Price Delivery Order is for the supply of HEMLIBRA 150 MG/ML VIALML, a specialty medication. The contract has an ultimate completion date of December 20, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This is a $24,673.08 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Hemlibra 105 mg/0.7 ml vials, a specialty medication. There is no set-aside designation, indicating this was an open competition. The contract has an ultimate completion date of March 31, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $24,673.08 to AmerisourceBergen Drug Corp for the supply of Hemlibra 105 mg/0.7 mL vials. This firm fixed-price, non-set-aside contract was executed on May 30, 2025, with an ultimate completion date of June 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Hemlibra is a bispecific monoclonal antibody used in the treatment of hemophilia A and B, representing a...